Pharmaceutical Technology

January Issue Preview

Pharmaceutical Technology is the only peer-reviewed publication serving the largest requested circulation of 38,100 BPA-audited subscribers (June 2011 BPA Statement). Here is the November editorial lineup to give you a heads up on the coverage in this issue and to assist you in your decision to advertise in Pharmaceutical Technology this month.

Ad Close is December 3.

Cover Story: A look Ahead in BioPharmaceuticals
Amy Ritter, Pharmaceutical Technology

This article will examine the challenges in production and qualification of a growing type of therapy: antibody-drug conjugates, which combine monoclonal antibodies and cytotoxic molecules to treat conditions such as cancer. It will also address niche technology advances used to link drugs to antibodies. These drugs are considered to be the next blockbuster drugs in industry.

VALUE ADDED MARKETING SUPPORT WITH YOUR JANUARY DISPLAY AD:

• FREE 1/3 Page Profile Outlining Products & Services
• FREE 4-Color Print Release

EDITORIAL PREVIEW
January 2012
Editorial Content Subject To Change

Pharma Ingrediants (APIs and Excipients): Small Molecule Synthesis
Patricia Van Arnum, Pharmaceutical Technology

FDA Perspectives: Designation of Regulatory Starting Materials in the Manufacturing of Drug Substances: Impact on ANDA Review Time
Barbara Scott, Office of Pharmaceutical Science, FDA

COLUMNS

From the Editor
PharmTech Talk
Agent in Place
In the Field: Report from Europe
In the Spotlight: Focus on Automation/Process Control/IT
Washington Report
BioForum
Packaging Forum
Insider Solutions
Pharma Capsules: Industry Leader Q&A
Outsourcing Outlook
Viewpoint

We look forward to hearing from you! Contact Your Representative:

Suzanne Fillweber Tel: 732-346-3024 Email	Paul Milazzo Tel: 732-346-3025 Email	Irene Onesto Tel: 847-496-4619 Email	Mike Tracey Tel: 732-346-3027 Email